SELBYVILLE, Del., Oct. 22, 2018 /PRNewswire-PRWeb/ -- Global In-vitro Diagnostic Services Market revenue is poised to
Growing prevalence of chronic diseases such as cancer should have positive impact on the demand for in-vitro diagnostic (IVD) services. According to WHO, in 2015, there were around 8.8 million deaths globally due to cancer that will augment demand for IVD services. Also, as reported by World Cancer Research Fund International, there were around 1.4 million cases of colorectal cancer globally that will assure inflated demand for diagnostic services in forthcoming years. However, excessive cost of the diagnostic services and software utilized will restrain the industry growth.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2889
Software segment will grow at 4.5% and is expected to have similar growth trends over the estimated forecast. Use of software in clinics, hospitals and pathology laboratories to maintain the data of patients should impact the segmental growth positively. Furthermore, availability of reliable and efficient software systems will enhance the business growth in the forthcoming years.
Testing services segment of in-vitro diagnostic services market will grow at 5.7% over the forecast timeline and the high segmental growth will be attributed to the availability of superior quality in-vitro diagnostic services. Moreover, increasing mortality rates due to cancer and other viral infections should augment the business growth over forecast time-frame.
Laboratories segment held an enormous market share of 29.3% in 2017 and is anticipated to follow high growth trends in upcoming years. Increase in rate of detection of diabetes cases in South African and Asian countries will augment the segmental growth and escalate the demand for in-vitro diagnostic services. Additionally, growing incidence of chronic infections such as HIV and others will ensure high demand for laboratory diagnostic services. According to U.S. Statistics, around 1.1 million people in the U.S. were infected with AIDS that will positively influence business growth.
Browse key In-vitro Diagnostic Services Market insights from the 2018 report spread across 185, pages offering 226 market data tables as well as 8 figures & charts along with the table of contents:
U.S. market accounted for 89.7% regional revenue share in 2017 and high business growth can be attributed to the increasing geriatric population suffering from chronic disease such as diabetes. As per CDC in 2015, around 30.3 million Americans were detected with diabetes that should upsurge the demand for diagnostic services in near future. Also, developments in healthcare infrastructure will positively impact the business growth.
China in-vitro diagnostic services market was valued at USD 2.2 billion in 2017, as a result of the increasing incidences of cancer. Around 7500 people in China die due to cancer. Due to availability of superior quality diagnostic services, the mortality rates have reduced drastically in the recent years. Also, growing adoption rate of point-of-care testing services by the elderly based population requiring critical monitoring will upsurge the regional growth in forthcoming years.
11 companies active and profiled in the global In-vitro Diagnostic Services Market research include BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche diagnostics, Siemens, Sysmex and Thermo Fisher.
Make an Inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2889
Browse Related Reports:
Molecular Diagnostics Market Size Forecast 2018 – 2024:
PCR application segment accounted for USD 3.1 billion in 2017 and is estimated to dominate the industry throughout the analysis period. Some of the key players operating in global molecular diagnostics market are Abbott Molecular Cepheid, BioMerieux's, Roche diagnostics, Danaher Corporation, Siemens Healthcare, Qiagen Gaithersburg, Johnson and Johnson, Agilent (Dako), GenMark diagnostics, Analytik Jena and Alere Inc. Read more at
Ambulatory Surgical Centers Market Size Outlook 2018 – 2024 Forecast:
Germany accounted for more than 25% of European market share in 2017, helped by increasing demand for surgeries such as eye surgeries and skin surgeries. Some of the notable players operating in the global market are Hospital Corporations of America, Ambulatory Surgical Centres of America, Physicians Endoscopy, Proliance surgeons, Surgical Care affiliates, AmSurg, Surgcenter Development, ASD Management, Regent Surgical Health, Covenant Surgical Partners, Surgical Management Professionals, Surgery Partners and Tenet/USPI. Read more at
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us: Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: email@example.com Web: https://www.gminsights.com Blog: http://exsoft.org/category/health/
SOURCE Global Market Insights
Subscribe to our Free Newsletters!